Back
Opus Genetics, Inc. 10K Form
Sell
47
IRD
Opus Genetics, Inc.
Last Price:
$2.24
Seasonality Move:
-17.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IRD News And Ratings
See the #1 stock for the next 7 days that we like better than IRD
IRD Financial Statistics
Sales & Book Value
| Annual Sales: | $11M |
|---|---|
| Cash Flow: | $-6.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.09 |
| Price / Book: | 25.77 |
Profitability
| EPS (TTM): | -1.71880 |
|---|---|
| Net Income (TTM): | $-68.2M |
| Gross Margin: | $11M |
| Return on Equity: | -490.41% |
| Return on Assets: | -170.31% |
Opus Genetics, Inc. Earnings Forecast
Key Opus Genetics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for IRD is 99.91%.
-
The Selling, General & Administrative Expenses for IRD have been equal to 165.71% of Gross Profit Margin.
-
The Research & Development expenses have been 244.28% of Revenue.
-
The Net Earning history of IRD is -523.40% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Opus Genetics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IRD |
| Website: | opusgtx.com |
Debt
| Debt-to-Equity Ratio: | 0.18 |
|---|---|
| Current Ratio: | 1.23 |
| Quick Ratio: | 1.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IRD Technical Analysis vs Fundamental Analysis
Sell
47
Opus Genetics, Inc. (IRD)
is a Sell
Is Opus Genetics, Inc. a Buy or a Sell?
-
Opus Genetics, Inc. stock is rated a SellThe current Opus Genetics, Inc. [IRD] share price is $2.23. The Score for IRD is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.